Screener
Arcutis Biotherapeutics, Inc. ARQT ZORYVE foam — Product revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| ZORYVE cream 0.3% | $35,327 | $27,675 | $67,997 | $51,062 |
| ZORYVE foam | 67,377 | 39,212 | 117,004 | 69,452 |
| ZORYVE cream 0.15% | 24,231 | 14,617 | 45,972 | 24,836 |
| ZORYVE cream 0.05% | 2,926 | — | 4,286 | — |
| Total product revenue, net | 129,861 | 81,504 | 235,259 | 145,350 |
| Other revenue | — | — | — | 2,000 |
| Total revenues | $129,861 | $81,504 | $235,259 | $147,350 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s ZORYVE foam — product revenue, net?
- Arcutis Biotherapeutics, Inc. (ARQT) reported ZORYVE foam — product revenue, net of $67.38M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s ZORYVE foam — product revenue, net changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s ZORYVE foam — product revenue, net increased by 71.8% year-over-year, from $39.21M to $67.38M.
- What does ZORYVE foam — product revenue, net mean?
- This metric represents the total net sales generated from a specific pharmaceutical product formulation after accounting for returns, discounts, and rebates. It serves as a primary indicator of market adoption, commercial traction, and the successful transition from clinical development to commercialization for a key dermatological therapeutic. Tracking this revenue stream helps investors evaluate the product's growth trajectory and its contribution to the company's overall top-line performance.
Ask your AI about Arcutis Biotherapeutics, Inc.'s zoryve foam — product revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude